Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Jul
27
Today In Oncology
Does Bilateral Mastectomy for Unilateral Breast Cancer Impact Mortality
Patients With Prostate Cancer Social Factors May Be Tied to Racial Disparities in Cardiovascular Outcomes
Update on LEANer Trial in Patients With Breast Cancer
Triplet as Initial Salvage Treatment for Advanced Germ Cell Tumors Long-Term Outcomes
New Study Highlights Improvements in Treating Pediatric Patients With Retinoblastoma
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Conexiant Oncology Logo